Yandong U. Shen

Royal North Shore Hospital
Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

The spectrum of tonsillar involvement in chronic lymphocytic leukemia (CLL).

The spectrum of tonsillar involvement in chronic lymphocytic leukemia (CLL).

Journal: Leukemia & lymphoma

Published: January 20, 2026

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.

Journal: HemaSphere

Published: May 14, 2024

The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro.

The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro.

Journal: Leukemia & lymphoma

Published: January 16, 2024

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.

Journal: EClinicalMedicine

Published: July 31, 2023

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.

Journal: Blood advances

Published: July 28, 2023

Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL.

Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL.

Journal: British journal of haematology

Published: June 30, 2023

An extension of estimating equations to model longitudinal medical cost trajectory with Medicare claims data linked to SEER cancer registry.

An extension of estimating equations to model longitudinal medical cost trajectory with Medicare claims data linked to SEER cancer registry.

Journal: The annals of applied statistics

Published: March 01, 2023

Metastatic squamous cell carcinoma in chronic lymphocytic leukaemia in a haematology-dermatology multidisciplinary clinic.

Metastatic squamous cell carcinoma in chronic lymphocytic leukaemia in a haematology-dermatology multidisciplinary clinic.

Journal: The Australasian journal of dermatology

Published: August 06, 2022

Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.

Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.

Journal: Blood

Published: July 20, 2022

Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical management.

Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical management.

Journal: Leukemia & lymphoma

Published: June 29, 2022

Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell lines.

Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell lines.

Journal: Nucleosides, nucleotides & nucleic acids

Published: December 10, 2021

Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.

Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.

Journal: EJHaem

Published: November 16, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026